These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 16566443

  • 1. Detection of adventitious viruses in biologicals--a rare occurrence.
    Nims RW.
    Dev Biol (Basel); 2006; 123():153-64; discussion 183-97. PubMed ID: 16566443
    [Abstract] [Full Text] [Related]

  • 2. Issues of biological assays for viral vaccines.
    Lee CK.
    Dev Biol Stand; 1996; 88():41-7. PubMed ID: 9119161
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Safety characterization of HeLa-based cell substrates used in the manufacture of a recombinant adeno-associated virus-HIV vaccine.
    Tatalick LM, Gerard CJ, Takeya R, Price DN, Thorne BA, Wyatt LM, Anklesaria P.
    Vaccine; 2005 Apr 08; 23(20):2628-38. PubMed ID: 15780446
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations. Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22-23 April 2009, Bethesda, USA.
    Knezevic I, Stacey G, Petricciani J, Sheets R, WHO Study Group on Cell Substrates.
    Biologicals; 2010 Jan 08; 38(1):162-9. PubMed ID: 19818645
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Process scale considerations in evaluation studies and scale-up.
    Walter JK, Werz W, Berthold W.
    Dev Biol Stand; 1996 Jan 08; 88():99-108. PubMed ID: 9119169
    [Abstract] [Full Text] [Related]

  • 14. Validation of purification procedures for removing and/or inactivating viruses in biologicals: points to consider.
    Vicari G.
    Dev Biol Stand; 1991 Jan 08; 75():227-32. PubMed ID: 1794625
    [Abstract] [Full Text] [Related]

  • 15. Approaches to the release of a master cell bank of PER.C6 cells; a novel cell substrate for the manufacture of human vaccines.
    Lewis JA, Brown EL, Duncan PA.
    Dev Biol (Basel); 2006 Jan 08; 123():165-76; discussion 183-97. PubMed ID: 16566444
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evolution of approaches to viral safety issues for biological products.
    Lubiniecki AS.
    PDA J Pharm Sci Technol; 2011 Jan 08; 65(6):547-56. PubMed ID: 22294576
    [Abstract] [Full Text] [Related]

  • 18. Methods for the detection of adventitious viruses in cell cultures used in the production of biotechnology products.
    Poiley JA.
    Bioprocess Technol; 1990 Jan 08; 10():483-94. PubMed ID: 1367069
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.